Digital Health Startups

Cortrium develops a long-term ECG solution that combines wearable hardware, algorithms, and human expertise for recording and reporting to identify arrhythmias and prevent heart disease and stroke. It serves cardiology and healthcare professionals and their patients, operating across multiple countries through partners and distributors.

2 investors

Cosan Group provides virtual care management infrastructure and intelligent automation services that extend clinical care beyond office visits for healthcare providers. The platform helps practices manage patient care remotely, improve health outcomes, and reduce costs while emphasizing compassionate, evidence-based care.

2 investors

Cosm develops advanced pessary devices for conservative (non-surgical) treatment of pelvic floor disorders including prolapse and incontinence in women. The company focuses on addressing an underserved market through the Gynethotics product line.

2 investors

Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.

2 investors

Cottonball delivers custom-compounded prescription skincare formulas prescribed by dermatologists based on individual skin profiles, shipped directly to customers. The service combines telemedicine consultation with pharmacy compounding to create personalized skincare treatments at specified ingredient concentrations.

2 investors

Cove builds brain data analytics tools that combine data engineering and neuroscience to support patient care. The company is developed by a team of physicians, neuroscientists, and software engineers.

2 investors

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

2 investors

Cresco Labs is a vertically integrated cannabis producer and retailer that cultivates, manufactures, and distributes cannabis products through national brands and Sunnyside dispensaries. The company operates cultivation and manufacturing facilities, wholesale distribution, and a retail network focused on quality, consumer education, and brand building in the legal cannabis market.

2 investors

Cristal Therapeutics develops therapeutics in the life sciences sector. The page does not provide sufficient details about specific products, customer segments, or market focus to construct a fuller description.

2 investors

Crossover Health operates an integrated primary care delivery model centered on member experience, using proprietary technology and care structures to expand healthcare access and accountability. The company serves patients and employer groups seeking preventative and primary care outside traditional healthcare system navigation.

2 investors

CrowdHealth offers a community-based approach to health care funding, where members help cover each other's medical bills as an alternative to traditional health insurance. It presents itself as a health-focused service for individuals and families.

2 investors

Cubtale provides a digital platform that helps parents capture and organize routine childcare data, share information with health professionals, and track developmental milestones. The service delivers personalized insights to improve parental caregiving.

2 investors

CuePath makes smart adhesive stickers (CuePack) that attach to standard medication blister packs, recording when each blister is opened and syncing that adherence data to the cloud and clinical trial management systems such as REDCap. The product serves clinical researchers and contract research organizations running distributed, placebo-controlled drug trials, particularly for controlled substances and substance use disorder treatment.

2 investors

NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.

2 investors

Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.

2 investors

CureBay is an online healthcare platform in India offering genuine medicine delivery, lab test bookings, and doctor consultations. It serves consumers seeking affordable access to healthcare services.

2 investors

Curejoy is a digital health and wellness content platform that aggregates information about natural health practices and home remedies for a global audience. It serves health-conscious consumers seeking credible wellness information and expert advice through its website, social media, and newsletters.

2 investors

CureMetrix develops FDA-cleared AI software that analyzes routine screening mammograms to detect, quantify, and contextualize Breast Arterial Calcifications (BAC) for radiologists. It serves breast imaging providers in the US, adding cardiovascular-risk screening to standard mammography exams.

2 investors

CurieDx is a screening tool that provides a patient screening interface and provider workflow for medical practices, offered to clinicians across specialties. It is delivered as a diagnostic software product for healthcare providers.

2 investors

Curoflow provides a white-label digital healthcare platform for care providers, combining booking, triage, electronic medical records, a patient portal, payments, and business support in one system. Built for the European market with local hosting and GDPR/PDL compliance, it serves clinics and larger care chains.

2 investors

Custom Surgical develops digitalization and AI tools for eye care professionals to support faster and more accessible diagnoses. The company serves the ophthalmology and eye health market internationally.

2 investors

Cyclana Bio is a biotech company developing therapeutic programs focused on the extracellular matrix and tissue-level disease biology, with a flagship focus on women's health conditions such as endometriosis. Based at the Babraham Research Campus in Cambridge, UK, its work builds on academic research into how the non-cellular component of tissue drives health and disease.

2 investors

Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders. Its lead asset, EG110A, is in clinical development for neurogenic detrusor overactivity (neurogenic bladder dysfunction).

2 investors

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

2 investors